U.S. Pays Pfizer, BioNTech $1.95 Billion to Secure Millions of COVID-19 Vaccine Doses

<p>The U.S. has agreed to pay Pfizer and BioNTech nearly $2 billion to secure 100 million doses of their experimental coronavirus vaccine. It still needs to go through phase three trials and be approved by the FDA, but the race is on to secure as many doses as possible. Operation Warp Speed has struck similar deals with other vaccine developers as well. Jared Hopkins, Pharma reporter at the WSJ, joins us for all the money being poured into vaccines.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>